Haas, N. B., Puligandla, M., Allaf, M. E., McDermott, D. F., Drake, C. G., Signoretti, S., … Carducci, M. A. (2020). PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).

Haas, Naomi B., Maneka Puligandla, Mohamad E. Allaf, David F. McDermott, Charles G. Drake, Sabina Signoretti, David Cella, et al. “PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.

Haas NB, Puligandla M, Allaf ME, McDermott DF, Drake CG, Signoretti S, et al. PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143). In: JOURNAL OF CLINICAL ONCOLOGY. 2020.

Haas, Naomi B., et al. “PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.

Haas NB, Puligandla M, Allaf ME, McDermott DF, Drake CG, Signoretti S, Cella D, Gupta RT, Shuch BM, Lara P, Kapoor A, Heng DYC, Leibovich BC, Michaelson MD, Choueiri TK, Jewett MAS, Maskens D, Harshman LC, Master VA, Carducci MA. PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143). JOURNAL OF CLINICAL ONCOLOGY. 2020.